OncoNova Discontinues Phase III Pancreatic Cancer Trial

barbara.lempert Onconova Announces Results of Interim Analysis of Metastatic Pancreatic Cancer Study NEWTOWN, Pa., Dec. 17, 2013 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. ...

EU watchdogs demand info on AstraZeneca’s disputed Brilinta trial

Tracy Staton Last week, AstraZeneca succinctly disclosed that Department of Justice investigators are digging into its data on the blood thinner Brilinta. Now, European regulators are ...

Shire’s ADHD med Vyvanse holds off binge eating in trial for new indication

Tracy Staton Shire shares spiked to an all-time high after the company revealed new data showing its ADHD drug Vyvanse was effective at treating binge eating disorder. FiercePharma ...

Immunocore Starts Phase IIa Trial for Melanoma

mia.burns Immunocore initiates Phase IIa clinical trial for IMCgp100 in melanoma (Oxford, UK, 31 October 2013) Immunocore Limited, the Oxford-based biotechnology company developing ...

CEVEC Completes Phase I Trial

mia.burns Completion of a “First in Human” Clinical Phase I Study with a Therapeutic Protein Derived from CAP® Cells Cologne, Germany, November 1, 2013 / B3C newswire / – ...

Study: Drug developers routinely–and unethically–leave trial data in the dark

John Carroll Drug companies routinely herald their concern for patients as the leading reason why they spend billions of dollars on drug research. But a new study questions Big Pharma's ...

Interim analysis of triple-blind, randomized iMRI trial proves better results for glioma patients

barbara.lempert Interim analysis of triple-blind, randomized iMRI trial proves better results for glioma patients Fudan University neurosurgeons receive journal award at CNS for high-ranking ...

Regeneron and Bayer’s Eylea turns out positive BRVO trial data

Carly Helfand The positive data keep rolling in for Regeneron's Eylea. Monday, the company said its blockbuster eye drug improved vision loss in patients with a condition caused ...

First Patient Enrolled in Phase III Trial Evaluating The Medicines Company’s Angiomax

barbara.lempert First Patient Enrolled in Phase III Trial Evaluating The Medicines Company’s Angiomax(R) (Bivalirudin) in Patients Undergoing Peripheral Endovascular ...

Ariad halts Iclusig trial enrollment on blood-clot worries

Tracy Staton After investigators tracked a rising rate of blood clots among leukemia patients in ongoing clinical studies, the biotech slammed the brakes on new trial enrollment and ...

Amid shutdown, NIH forced to turn away new trial patients

Carly Helfand Thanks to the government shutdown, about 73% of NIH staff have seen their jobs put on hold–and no staff means no new studies. As The Washington Post reports, the ...

National Minority Quality Forum to Launch the National Clinical Trial Network With Microsoft

mia.burns February 14, 2013–The National Minority Quality Forum announced today a collaboration between its National Health Index (NHI) and Microsoft Corporation to launch the ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS